Immunome, Inc.IMNMNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P37
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -21.66% |
| Q3 2025 | -32.40% |
| Q2 2025 | -4.22% |
| Q1 2025 | 48.11% |
| Q4 2024 | -70.38% |
| Q3 2024 | -30.39% |
| Q2 2024 | 72.10% |
| Q1 2024 | -39.79% |
| Q4 2023 | -2031.97% |
| Q3 2023 | 21.81% |
| Q2 2023 | -30.14% |
| Q1 2023 | 45.16% |
| Q4 2022 | 8.75% |
| Q3 2022 | 4.38% |
| Q2 2022 | 23.42% |
| Q1 2022 | -48.41% |
| Q4 2021 | -1.71% |
| Q3 2021 | -47.30% |
| Q2 2021 | -34.45% |
| Q1 2021 | 4.30% |
| Q4 2020 | 51.38% |
| Q3 2020 | -209.11% |
| Q2 2020 | -1.23% |
| Q1 2020 | 8.38% |
| Q4 2019 | -6.76% |
| Q3 2019 | -14.40% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |